Doctor profile · Federal record
Dr. Kalista Engelman, DO
Rheumatology Physician (CMS: Rheumatology) · Rheumatology Physician · Kansas City, MO
- NPI 1043440944
- Accepts Medicare
- MIPS 87.6 / 100 · 2023
- 11 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
4440 Broadway Blvd
Kansas City, MO 641113315
(816) 531-0930
fax (816) 753-2671 - Additional location
-
4330 Wornall RD Ste 40
Kansas City, MO 641115940
Credentials & registration
- NPI registered
- July 2009 — 17 yrs on file
- Profile last updated
- March 15, 2021
- Year of graduation
- 2015 — 11 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State licenses (2)
- Missouri #2015001548 · Kansas #05-36624
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1043440944. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
216,209
Distinct HCPCS
10
Medicare allowed
$2,185,217
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 164,200 | 45 | $5 | |
J3262 |
Injection, tocilizumab, 1 mg | 16,120 | 19 | $5 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 10,875 | 54 | $42 | |
J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 4,350 | 21 | $45 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 3,750 | 17 | $13 | |
J0897 |
Injection, denosumab, 1 mg | 3,720 | 38 | $23 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 3,630 | 38 | $32 | |
J9312 |
Injection, rituximab, 10 mg | 2,500 | 14 | $73 | |
96372 |
Injection of drug or substance under skin or into muscle | 992 | 144 | $14 | |
36415 |
Insertion of needle into vein for collection of blood sample | 745 | 391 | $4 |
In context: peer comparison
Among 6 peers in Kansas City Rheumatology Physician, average services per provider: 3,614. This provider delivers 60× the peer median.Medicare Part D · 2023
Top prescriptions
Total claims
3,324
Patients
958
Total drug cost
$516,136
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate | Generic | 804 | 205 | $67,647 |
| Methotrexate (Methotrexate Sodium) | Brand | 585 | 166 | $21,540 |
| Prednisone | Generic | 292 | 112 | $2,513 |
| Leflunomide | Generic | 226 | 67 | $15,211 |
| Meloxicam | Generic | 221 | 79 | $1,417 |
| Tramadol Hcl | Generic | 208 | 40 | $2,319 |
| Sulfasalazine | Generic | 204 | 52 | $6,269 |
| Sulfasalazine Dr (Sulfasalazine) | Brand | 172 | 48 | $13,826 |
| Celecoxib | Generic | 142 | 50 | $4,161 |
| Folic Acid | Generic | 119 | 35 | $523 |
Frequently asked questions
What is Dr. Kalista Engelman's medical specialty?
Dr. Kalista Engelman practices Rheumatology Physician in Kansas City, MO.
Where does Dr. Kalista Engelman practice?
Dr. Kalista Engelman practices at 4440 Broadway Blvd, Kansas City, MO 641113315. Office phone: 8165310930.
What is Dr. Kalista Engelman's NPI?
Dr. Kalista Engelman's National Provider Identifier (NPI) is 1043440944, issued by NPPES.
Does Dr. Kalista Engelman accept Medicare assignment?
Yes. Dr. Kalista Engelman accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Kalista Engelman commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129). Source: CMS Medicare Physician & Other Practitioners file.